Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04616963
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-06
First Post:
2020-07-13
Brief Title:
EmtricitabineTenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
Sponsor:
University of California San Diego
Organization:
University of California San Diego
Organization Data
Organization:
University of California San Diego
Class:
OTHER
Study ID:
CCTG 605
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of California San Diego
Lead Sponsor Class:
OTHER
Responsible Party:
Sheldon Morris
Responsible Party Title:
Clinical Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of California San Diego
Old Name:
None
Old Organization:
None